Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Roche scientists disclose new series of protein kinase inhibitors and their use

June 8, 2000

Selective EP2-binding agents and their therapeutic use claimed by Ono

June 8, 2000

Vical's cationic lipid formulation selectively enhances antibody immune response to antigen pDNA

June 7, 2000

Intellivax and Active Biotech form partnership to develop streptococcal vaccine

June 7, 2000

Efforts to develop malaria vaccines reviewed at ECCMID; new candidate from SB highlighted

June 2, 2000

Repligen acquires U.S. patent rights to CTLA4-Ig

June 2, 2000

Neisseria outer membrane proteins useful for the therapy, diagnosis of infections

June 1, 2000

Immunosuppressive and antitumor properties of new histone deacetylase inhibitor WF-27082B

May 31, 2000

Enzo Biochem's tolerance induction therapy may be useful in GVHD

May 31, 2000

SciClone's Zadaxin now available in Italy

May 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...